A

Aspira Women's Health

AWH

1.29000
USD
-0.01
(-0.77%)
مغلق
حجم التداول
400
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
14,296,016
أصول ذات صلة
A
ADM
-1.490
(-2.40%)
60.490 USD
A
ASIX
-1.290
(-4.60%)
26.740 USD
C
CF
-0.560
(-0.73%)
75.810 USD
C
CTVA
-3.100
(-5.52%)
53.020 USD
F
FMC
5.983
(10.26%)
64.323 USD
M
MOS
-0.920
(-3.09%)
28.860 USD
N
NTR
-1.280
(-2.50%)
49.910 USD
S
SMG
-3.530
(-4.49%)
75.150 USD
الأخبار المقالات

العنوان: Aspira Women's Health

القطاع: Healthcare
الصناعة: Diagnostics & Research
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.